Table 1.
DRUG CLASS | DRUGS | MITOCHONDRIAL EFFECTS | EFFECT ON INSULIN SENSITIVITY | REFERENCE |
---|---|---|---|---|
NRTI’s | Zidovudine | inhibits the polymerase that replicates mtDNA, thus preventing mitochondrial replication. | Decreases insulin sensitivity | (21, 28) |
Stavudine | MtDNA depletion or damage. Mitochondrial toxicity which induces lipodystrophy |
Decreases insulin sensitivity | (29, 30) | |
Statins | Simvastatin | reduce coenzyme Q10 (CoQ10) levels | Decreases insulin sensitivity | (31) |
Pravastatin | Reduces coupling between electron transport chain and oxidative phosphorylation | Impairs insulin signalling and decreases insulin sensitivity | (32, 33) | |
Antipsychotics | Chlorpromazin | Inhibits ATPase activit | Exacerbates hepatic insulin sensitivity | (34) |
Haloperidol | Increases formation of mitochondrial ROS and mitochondrial mass | Increase insulin secretion | (35–37) | |
Antidepressants | Amitriptyline | Induces ROS formation | Decreases insulin sensitivity | (38) |
Sertraline | Perturbs mitochondrial membrane and causes swelling | Increases pancreatic insulin secretion | (36) | |
Chemotherapy agents | Doxorubicin | Increases ROS, mtDNA adduct and iron overload | Impairs systemic insulin sensitivity | (39) |
Cisplatin | Impairs ETC and increase ROS formation. | Impairs insulin secretion. | (38, 40) | |
Tamoxifen | Inhibits mitochondrial respiration and elevated mitochondrial lipid peroxidation. | Decreases hepatic insulin sensitivity | (41, 42) | |
Antibiotic | Clarithromycin | inhibits the mitochondrial protein synthesis |
Improves insulin sensitivity | (28, 31) |
Doxycycline | inhibits the mitochondrial protein synthesis |
Improve insulin sensitivity | (43, 44) | |
Antihypertensives | carvedilol | Inhibits mitochondrial oxygen consumption Mild uncoupling of mitochondrial oxidative phosphorylation |
Increases insulin sensitivity | (45–47) |
Captopril | Decreases mitochondrial ATP synthase activity | Improves hepatic insulin sensitivity | (48, 49) | |
Anti-epileptics | Valproic acid | Inhibits the TCA cycle and mitochondrial fatty acid oxidation | Enhances insulin resistance | (50, 51) |
Phenytoin | Inhibits ETC | Inhibits insulin release | (52, 53) | |
Carbamazepine | Inhibits mitochondrial respiration. | Improves insulin sensitivity | (52, 54) | |
Analgesics | Paracetamo | Induce oxidative stress leading to mtDNA depletion or damage | Improves insulin secretion | (55–58) |
Tramadol | Directly inhibits mitochondrial fatty acid oxidation. OXPHOS uncoupling |
Enhances hepatic insulin sensitivity | (59–61) | |
Diclofenac | Increases mitochondrial oxidative stress | Improves insulin sensitivity | (60–62) | |
Anticoagulants | Aspirin | Uncouples mitochondrial oxidation. | Improves insulin sensitivity | (63–66) |
Clopidogrel | Decreases mitochondrial membrane potential Increase ROS production |
Improves insulin sensitivity | (61) |